Cargando…

Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations

PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayama, Shusuke, Matsuura, Taeko, Yasuda, Koichi, Takao, Seishin, Fujii, Takaaki, Miyamoto, Naoki, Umegaki, Kikuo, Shimizu, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170293/
https://www.ncbi.nlm.nih.gov/pubmed/32150329
http://dx.doi.org/10.1002/acm2.12844
_version_ 1783523865113133056
author Hirayama, Shusuke
Matsuura, Taeko
Yasuda, Koichi
Takao, Seishin
Fujii, Takaaki
Miyamoto, Naoki
Umegaki, Kikuo
Shimizu, Shinichi
author_facet Hirayama, Shusuke
Matsuura, Taeko
Yasuda, Koichi
Takao, Seishin
Fujii, Takaaki
Miyamoto, Naoki
Umegaki, Kikuo
Shimizu, Shinichi
author_sort Hirayama, Shusuke
collection PubMed
description PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence of RBE on the linear energy transfer (LET). To conduct as accurate a clinical evaluation as possible in this circumstance, it is desirable that the dosimetric parameters derived by TPS ([Formula: see text]) are close to the “true” values derived with the variable RBE models ([Formula: see text]). As such, in this study, the closeness of [Formula: see text] to [Formula: see text] was compared between planning target volume (PTV)‐based and robust plans. METHODS: Intensity‐modulated proton therapy (IMPT) treatment plans for two Radiation Therapy Oncology Group (RTOG) phantom cases and four nasopharyngeal cases were created using the PTV‐based and robust optimizations, under the assumption of a constant RBE of 1.1. First, the physical dose and dose‐averaged LET (LET(d)) distributions were obtained using the analytical calculation method, based on the pencil beam algorithm. Next, [Formula: see text] was calculated using three different RBE models. The deviation of [Formula: see text] from [Formula: see text] was evaluated with D (99) and D (max), which have been used as the evaluation indices for clinical target volume (CTV) and organs at risk (OARs), respectively. The influence of the distance between the OAR and CTV on the results was also investigated. As a measure of distance, the closest distance and the overlapped volume histogram were used for the RTOG phantom and nasopharyngeal cases, respectively. RESULTS: As for the OAR, the deviations of [Formula: see text] from [Formula: see text] were always smaller in robust plans than in PTV‐based plans in all RBE models. The deviation would tend to increase as the OAR was located closer to the CTV in both optimization techniques. As for the CTV, the deviations of [Formula: see text] from [Formula: see text] were comparable between the two optimization techniques, regardless of the distance between the CTV and the OAR. CONCLUSION: Robust optimization was found to be more favorable than PTV‐based optimization in that the results presented by TPS were closer to the “true” values and that the clinical evaluation based on TPS was more reliable.
format Online
Article
Text
id pubmed-7170293
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71702932020-04-21 Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations Hirayama, Shusuke Matsuura, Taeko Yasuda, Koichi Takao, Seishin Fujii, Takaaki Miyamoto, Naoki Umegaki, Kikuo Shimizu, Shinichi J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence of RBE on the linear energy transfer (LET). To conduct as accurate a clinical evaluation as possible in this circumstance, it is desirable that the dosimetric parameters derived by TPS ([Formula: see text]) are close to the “true” values derived with the variable RBE models ([Formula: see text]). As such, in this study, the closeness of [Formula: see text] to [Formula: see text] was compared between planning target volume (PTV)‐based and robust plans. METHODS: Intensity‐modulated proton therapy (IMPT) treatment plans for two Radiation Therapy Oncology Group (RTOG) phantom cases and four nasopharyngeal cases were created using the PTV‐based and robust optimizations, under the assumption of a constant RBE of 1.1. First, the physical dose and dose‐averaged LET (LET(d)) distributions were obtained using the analytical calculation method, based on the pencil beam algorithm. Next, [Formula: see text] was calculated using three different RBE models. The deviation of [Formula: see text] from [Formula: see text] was evaluated with D (99) and D (max), which have been used as the evaluation indices for clinical target volume (CTV) and organs at risk (OARs), respectively. The influence of the distance between the OAR and CTV on the results was also investigated. As a measure of distance, the closest distance and the overlapped volume histogram were used for the RTOG phantom and nasopharyngeal cases, respectively. RESULTS: As for the OAR, the deviations of [Formula: see text] from [Formula: see text] were always smaller in robust plans than in PTV‐based plans in all RBE models. The deviation would tend to increase as the OAR was located closer to the CTV in both optimization techniques. As for the CTV, the deviations of [Formula: see text] from [Formula: see text] were comparable between the two optimization techniques, regardless of the distance between the CTV and the OAR. CONCLUSION: Robust optimization was found to be more favorable than PTV‐based optimization in that the results presented by TPS were closer to the “true” values and that the clinical evaluation based on TPS was more reliable. John Wiley and Sons Inc. 2020-03-09 /pmc/articles/PMC7170293/ /pubmed/32150329 http://dx.doi.org/10.1002/acm2.12844 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Hirayama, Shusuke
Matsuura, Taeko
Yasuda, Koichi
Takao, Seishin
Fujii, Takaaki
Miyamoto, Naoki
Umegaki, Kikuo
Shimizu, Shinichi
Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title_full Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title_fullStr Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title_full_unstemmed Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title_short Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
title_sort difference in let‐based biological doses between impt optimization techniques: robust and ptv‐based optimizations
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170293/
https://www.ncbi.nlm.nih.gov/pubmed/32150329
http://dx.doi.org/10.1002/acm2.12844
work_keys_str_mv AT hirayamashusuke differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT matsuurataeko differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT yasudakoichi differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT takaoseishin differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT fujiitakaaki differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT miyamotonaoki differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT umegakikikuo differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations
AT shimizushinichi differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations